Welcome to Yeast Infection Solution
.... a sure-fire, 100% guaranteed, clinically researched system that is backed by 25,000+ hours of nutritional expertise for eliminating yeast infection for good. This is a very rare, highly unique and potently powerful candida healing system, which very few people even know exists.......more
Updates on Treatment Of Candida
Glenmark Generics gets US FDA nod for clotrimazole cream USP
Glenmark Generics Inc., USA, the subsidiary of Glenmark Generics Ltd has received final ANDA approval from the US FDA for clotrimazole cream USP, 1 per cent and will commence marketing and distribution of this product in the US market immediately.
Read more...Remarkable New Yeast Control Formula Introduced by Top of the World Distributors®
Newly developed Candida Complex formula assists the body in restoring and maintaining a healthy internal bacterial balance.
Read more...PURE Biosciences SDC Antimicrobial Effective Against T. mentagrophytes in Preclinical Tests
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (NASDAQ: PURE) today announced that based on encouraging preclinical data it has granted two product-specific licenses to pharmaceutical development partner FTA Bioscience for development of a silver dihydrogen citrate (SDC)-based treatment for tinea unguium, also referred to as onychomycosis (nail fungus), as well as for tinea pedis (athletes foot ...
Read more...Perrigo files ANDA for butoconazole nitrate vaginal cream
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner of the New Drug Application as well as FemmePharma, the listed owner of the patent, of its ANDA filing. KV is a licensee under the patent. Perrigo believes it is first-to ...
Read more...Perrigo Confirms Filing for Generic Version of Gynazole-1® Cream and Announcement of Patent Infringement Lawsuit by KV ...
ALLEGAN, Mich., July 30 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner of the New Drug Application (NDA) as well as FemmePharma, the listed owner of the ...
Read more...
